| Product Information |
|
| Registration Number |
BR-1480
|
| Generic Name |
Spesolimab
|
| Brand Name |
Spevigo
|
| Dosage Strength |
450 mg/7.5 mL (60 mg/mL)
|
| Dosage Form |
Concentrate for Solution for
Infusion (IV)
|
| Classification |
Prescription (Rx) Drug
|
| Packaging |
7.5 mL-net content in 10 mL-capacity Type I glass vial with grey coated serum butyl rubber stopper, and aluminum crimp cap with dark blue plastic button (Box of 2's).
|
| Pharmacologic Category |
Interleukin inhibitors
|
| Manufacturer |
Boehringer Ingelheim Pharma GmbH & Co. KG
|
| Country of Origin |
Germany
|
| Trader |
|
| Importer |
Boehringer Ingelheim (Philippines), Inc.
|
| Distributor |
Boehringer Ingelheim (Philippines), Inc.
|
| Application Type |
Monitored Release (MR)
|
| Issuance Date |
05 April 2024
|
| Expiry Date |
05 April 2029
|